|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida.
Address reprint requests to: Gregory J. Locksmith, MD, Department of Obstetrics and Gynecology, University of Texas Medical Branch, 301 University Boulevard, Route 0587, Galveston, TX 77555-0587, E-mail: gjlocksm{at}utmb.edu
Objective: To determine the accuracy of amniotic fluid (AF) matrix metalloproteinase-9 measurements for diagnosing intra-amniotic infection in women with preterm labor.
Methods: We performed amniocenteses in 44 women between 22 and 35 weeks gestation who presented to our center with preterm labor and clinical suspicion of intra-amniotic infection. Each sample was analyzed by glucose measurement, Gram stain, and culture for aerobes, anaerobes, and mycoplasmas. We tested the AF for matrix metalloproteinase-9 using gelatin zymography and a commercial enzyme-linked immunosorbent assay (ELISA) system. We calculated accuracy and confidence intervals (CIs) for AF matrix metalloproteinase-9, glucose, and Gram stain for diagnosing intra-amniotic infection, using culture as the criterion standard.
Results: All patients who had matrix metalloproteinase-9 detectable by ELISA also demonstrated matrix metalloproteinase-9 by zymography. Six cases of intra-amniotic infection were confirmed by culture (prevalence 14%). The performance statistics of AF matrix metalloproteinase-9 for diagnosing intra-amniotic infection were: sensitivity 83% (95% CI 53, 99), specificity 95% (95% CI 88, 99), positive predictive value 71% (95% CI 37, 99), and negative predictive value 97% (95% CI 92, 99). Two women had false-positive results; one had gram-negative rods on the AF Gram stain and developed clinical signs and symptoms of chorioamnionitis several hours after amniocentesis and the other had a purulent vaginal discharge and an AF glucose level less than 15 mg/dL. Both delivered within 24 hours of amniocentesis.
Conclusion: Measuring matrix metalloproteinase-9 in the AF appeared to be reliable for diagnosing intra-amniotic infection. An elevated matrix metalloproteinase-9 concentration in the AF at a preterm gestational age may portend imminent delivery regardless of microbiologic confirmation of intra-amniotic infection.
This article has been cited by other articles:
![]() |
T.-D. Vu, Yun Feng, J. Placido, and S. E. Reznik Placental Matrix Metalloproteinase--1 Expression Is Increased in Labor Reproductive Sciences, April 1, 2008; 15(4): 420 - 424. [Abstract] [PDF] |
||||
![]() |
G. Garcia-Lopez, F. Vadillo-Ortega, H. Merchant-Larios, R. Maida-Claros, M. Osorio, D. Soriano-Becerril, H. Flores-Herrera, J. Beltran-Montoya, Y. Garfias-Becerra, and V. Zaga-Clavellina Evidence of in vitro differential secretion of 72 and 92 kDa type IV collagenases after selective exposure to lipopolysaccharide in human fetal membranes Mol. Hum. Reprod., June 1, 2007; 13(6): 409 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Pettker, I. A. Buhimschi, L. K. Magloire, A. K. Sfakianaki, B. D. Hamar, and C. S. Buhimschi Value of Placental Microbial Evaluation in Diagnosing Intra-amniotic Infection Obstet. Gynecol., March 1, 2007; 109(3): 739 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Zaga-Clavellina, H. Merchant-Larios, G. Garcia-Lopez, R. Maida-Claros, and F. Vadillo-Oretega Differential Secretion of Matrix Metalloproteinase-2 and -9 After Selective Infection With Group B Streptococci in Human Fetal Membranes Reproductive Sciences, May 1, 2006; 13(4): 271 - 279. [Abstract] [PDF] |
||||
![]() |
K. E. Kieser and T. F. Baskett A 10-Year Population-Based Study of Uterine Rupture Obstet. Gynecol., October 1, 2002; 100(4): 749 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Romero and T. Chaiworapongsa Preterm Labor, Intrauterine Infection, and the Fetal Inflammatory Response Syndrome NeoReviews, May 1, 2002; 3(5): e73 - 85. [Full Text] |
||||
![]() |
H. Harirah, S. E. Donia, and C.-D. Hsu Amniotic Fluid Matrix Metalloproteinase-9 and Interleukin-6 in Predicting Intra-Amniotic Infection Obstet. Gynecol., January 1, 2002; 99(1): 80 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McLaren, D.J. Taylor, and S.C. Bell Prostaglandin E2-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes Mol. Hum. Reprod., November 1, 2000; 6(11): 1033 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Devlieger, J. A.Deprest, E. Gratacos, R. Pijnenborg, R. Leask, and S. C.Riley Matrix metalloproteinases -2 and -9 and their endogenous tissue inhibitors in fetal membrane repair following fetoscopy in a rabbit model Mol. Hum. Reprod., May 1, 2000; 6(5): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |